Latest Andy Kielbania Stories
NEWARK, N.J., Dec. 3, 2010 /PRNewswire-FirstCall/ -- BioNeutral Group Inc, (OTC Bulletin Board: BONU), a specialty life science technology-based company, today announced that Dr.
NEWARK, N.J., Aug. 19 /PRNewswire/ -- BioNeutral announces successful testing of its Ygiene(TM) Hospital Grade antimicrobial against antibiotic-resistant microorganisms and spore forms of microorganisms which represent the major source of hospital acquired infections.
NEWARK, N.J., July 22 /PRNewswire/ -- BioNeutral announces successful independent laboratory test results which showed that Ygiene(TM) completely eliminates C. diff. spores in seconds. C. diff.
NEWARK, N.J., July 15 /PRNewswire/ -- BioNeutral announces successful test results for its Ygiene(TM) Anti-Mold Formulation. Testing of BioNeutral's Anti-Mold formulation was conducted by Dr.